{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:43:40Z","timestamp":1784803420395,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Northern New England Clinical Oncology Society"},{"name":"Dartmouth Brain Tumor Research Fund"},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001086"],"award-info":[{"award-number":["UL1TR001086"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11060-021-03865-w","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T10:31:52Z","timestamp":1634293912000},"page":"173-180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Systemic coagulation is activated in patients with meningioma and glioblastoma"],"prefix":"10.1007","volume":"155","author":[{"given":"Swaroopa","family":"Yerrabothala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett L.","family":"Gourley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Rakin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Wishart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S.","family":"Ernstoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo E.","family":"Fadul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8011-1437","authenticated-orcid":false,"given":"Deborah L.","family":"Ornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"3865_CR1","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1055\/s-0039-1687892","volume":"45","author":"AL Czap","year":"2019","unstructured":"Czap AL, Becker A, Wen PY (2019) Thrombotic Complications in Gliomas. Semin Thromb Hemost 45:326\u2013333. https:\/\/doi.org\/10.1055\/s-0039-1687892","journal-title":"Semin Thromb Hemost"},{"key":"3865_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/moh.0000000000000072","volume":"21","author":"A Falanga","year":"2014","unstructured":"Falanga A, Russo L, Milesi V (2014) The coagulopathy of cancer. Curr Opin Hematol 21:423\u2013429. https:\/\/doi.org\/10.1097\/moh.0000000000000072","journal-title":"Curr Opin Hematol"},{"key":"3865_CR3","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/1097-0142(20000801)89:3<640::AID-CNCR20>3.0.CO;2-E","volume":"89","author":"LC Marras","year":"2000","unstructured":"Marras LC, Geerts WH, Perry JR (2000) The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer 89:640\u2013646","journal-title":"Cancer"},{"key":"3865_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061354","author":"V Muster","year":"2020","unstructured":"Muster V, Gary T (2020) Incidence, therapy, and bleeding risk-cancer- associated thrombosis in patients with glioblastoma. Cancers. https:\/\/doi.org\/10.3390\/cancers12061354","journal-title":"Cancers"},{"key":"3865_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3171\/2018.7.Jns181175","volume":"132","author":"L Rinaldo","year":"2019","unstructured":"Rinaldo L, Brown DA, Bhargav AG, Rusheen AE, Naylor RM, Gilder HE, Monie DD, Youssef SJ, Parney IF (2019) Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature. J Neurosurg 132:10\u201321. https:\/\/doi.org\/10.3171\/2018.7.Jns181175","journal-title":"J Neurosurg"},{"key":"3865_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3171\/jns.2007.106.4.601","volume":"106","author":"TJ Semrad","year":"2007","unstructured":"Semrad TJ, O\u2019Donnell R, Wun T, Chew H, Harvey D, Zhou H, White RH (2007) Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg 106:601\u2013608. https:\/\/doi.org\/10.3171\/jns.2007.106.4.601","journal-title":"J Neurosurg"},{"key":"3865_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1182\/asheducation-2016.1.196","volume":"2016","author":"MB Streiff","year":"2016","unstructured":"Streiff MB (2016) Thrombosis in the setting of cancer. Hematol Am Soc Hematol Educ Program 2016:196\u2013205. https:\/\/doi.org\/10.1182\/asheducation-2016.1.196","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"3865_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11060-009-9886-4","volume":"93","author":"TA Cage","year":"2009","unstructured":"Cage TA, Lamborn KR, Ware ML, Frankfurt A, Chakalian L, Berger MS, McDermott MW (2009) Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas. J Neurooncol 93:151\u2013156. https:\/\/doi.org\/10.1007\/s11060-009-9886-4","journal-title":"J Neurooncol"},{"key":"3865_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11060-018-2810-z","volume":"138","author":"G Carrabba","year":"2018","unstructured":"Carrabba G, Riva M, Conte V, Di Cristofori A, Caroli M, Locatelli M, Castellani M, Bucciarelli P, Artoni A, Stocchetti N, Martinelli I, Rampini P (2018) Risk of post-operative venous thromboembolism in patients with meningioma. J Neurooncol 138:401\u2013406. https:\/\/doi.org\/10.1007\/s11060-018-2810-z","journal-title":"J Neurooncol"},{"key":"3865_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079170","volume":"8","author":"CV Eisenring","year":"2013","unstructured":"Eisenring CV, Neidert MC, Sabanes Bove D, Held L, Sarnthein J, Krayenbuhl N (2013) Reduction of thromboembolic events in meningioma surgery: a cohort study of 724 consecutive patients. PLoS ONE 8:e79170. https:\/\/doi.org\/10.1371\/journal.pone.0079170","journal-title":"PLoS ONE"},{"key":"3865_CR11","doi-asserted-by":"publisher","first-page":"106460","DOI":"10.1016\/j.clineuro.2020.106460","volume":"201","author":"R Fluss","year":"2021","unstructured":"Fluss R, Kobets AJ, Inocencio JF, Hamad M, Feigen C, Altschul DJ, Lasala P (2021) The incidence of venous thromboembolism following surgical resection of intracranial and intraspinal meningioma: a systematic review and retrospective study. Clin Neurol Neurosurg 201:106460. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106460","journal-title":"Clin Neurol Neurosurg"},{"key":"3865_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.clineuro.2014.06.001","volume":"123","author":"D Hoefnagel","year":"2014","unstructured":"Hoefnagel D, Kwee LE, van Putten EH, Kros JM, Dirven CM, Dammers R (2014) The incidence of postoperative thromboembolic complications following surgical resection of intracranial meningioma: a retrospective study of a large single center patient cohort. Clin Neurol Neurosurg 123:150\u2013154. https:\/\/doi.org\/10.1016\/j.clineuro.2014.06.001","journal-title":"Clin Neurol Neurosurg"},{"key":"3865_CR13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3171\/2010.6.Jns091974","volume":"114","author":"ME Sughrue","year":"2011","unstructured":"Sughrue ME, Rutkowski MJ, Shangari G, Chang HQ, Parsa AT, Berger MS, McDermott MW (2011) Risk factors for the development of serious medical complications after resection of meningiomas. Clin Article J Neurosurg 114:697\u2013704. https:\/\/doi.org\/10.3171\/2010.6.Jns091974","journal-title":"Clin Article J Neurosurg"},{"key":"3865_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008500.pub3","author":"M Di Nisio","year":"2014","unstructured":"Di Nisio M, Porreca E, Otten HM, Rutjes AW (2014) Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD008500.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"3865_CR15","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1182\/blood-2017-02-767285","volume":"129","author":"C Mantia","year":"2017","unstructured":"Mantia C, Uhlmann EJ, Puligandla M, Weber GM, Neuberg D, Zwicker JI (2017) Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin. Blood 129:3379\u20133385. https:\/\/doi.org\/10.1182\/blood-2017-02-767285","journal-title":"Blood"},{"key":"3865_CR16","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1055\/s-0039-1688493","volume":"45","author":"J Riedl","year":"2019","unstructured":"Riedl J, Ay C (2019) Venous thromboembolism in brain tumors: risk factors, molecular mechanisms, and clinical challenges. Semin Thromb Hemost 45:334\u2013341. https:\/\/doi.org\/10.1055\/s-0039-1688493","journal-title":"Semin Thromb Hemost"},{"key":"3865_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102190","volume":"96","author":"C Becattini","year":"2021","unstructured":"Becattini C, Di Nisio M, Franco L, Lee A, Agnelli G, Mandal\u00e0 M (2021) Treatment of venous thromboembolism in cancer patients: the dark side of the moon. Cancer Treat Rev 96:102190. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102190","journal-title":"Cancer Treat Rev"},{"key":"3865_CR18","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","volume":"5","author":"GH Lyman","year":"2021","unstructured":"Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA, Leavitt AD, Lee AYY, Macbeth F, Morgan RL, Noble S, Sexton EA, Stenehjem D, Wiercioch W, Kahale LA, Alonso-Coello P (2021) American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv 5:927\u2013974. https:\/\/doi.org\/10.1182\/bloodadvances.2020003442","journal-title":"Blood Adv"},{"key":"3865_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.5482\/hamo-14-08-0037","volume":"35","author":"C Dicke","year":"2015","unstructured":"Dicke C, Langer F (2015) Pathophysiology of Trousseau\u2019s syndrome. Hamostaseologie 35:52\u201359. https:\/\/doi.org\/10.5482\/hamo-14-08-0037","journal-title":"Hamostaseologie"},{"key":"3865_CR20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.thromres.2011.12.022","volume":"129","author":"MB Donati","year":"2012","unstructured":"Donati MB, Lorenzet R (2012) Thrombosis and cancer: 40 years of research. Thromb Res 129:348\u2013352. https:\/\/doi.org\/10.1016\/j.thromres.2011.12.022","journal-title":"Thromb Res"},{"key":"3865_CR21","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1182\/blood-2013-04-460139","volume":"122","author":"JE Geddings","year":"2013","unstructured":"Geddings JE, Mackman N (2013) Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood 122:1873\u20131880. https:\/\/doi.org\/10.1182\/blood-2013-04-460139","journal-title":"Blood"},{"key":"3865_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1615\/CritRevOncog.2018024859","volume":"22","author":"P Van Dreden","year":"2017","unstructured":"Van Dreden P, Epsilonlalamy I, Gerotziafas GT (2017) The role of tissue factor in cancer-related hypercoagulability, tumor growth, angiogenesis and metastasis and future therapeutic strategies. Crit Rev Oncog 22:219\u2013248. https:\/\/doi.org\/10.1615\/CritRevOncog.2018024859","journal-title":"Crit Rev Oncog"},{"key":"3865_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14130","author":"K Blix","year":"2018","unstructured":"Blix K, Gran OV, Severinsen MT, Cannegieter SC, Jensvoll H, Overvad K, Hammerstrom J, Tjonneland A, Naess IA, Braekkan SK, Rosendaal FR, Kristensen SR, Hansen JB (2018) Impact of time since diagnosis and mortality rate on cancer-associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.14130","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"3865_CR24","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1016\/j.thromres.2018.01.036","volume":"164","author":"AA Khorana","year":"2018","unstructured":"Khorana AA, Francis CW (2018) Risk prediction of cancer-associated thrombosis: appraising the first decade and developing the future. Thromb Res 164(Suppl 1):S70-s76. https:\/\/doi.org\/10.1016\/j.thromres.2018.01.036","journal-title":"Thromb Res"},{"key":"3865_CR25","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111:4902\u20134907. https:\/\/doi.org\/10.1182\/blood-2007-10-116327","journal-title":"Blood"},{"issue":"Suppl 2","key":"3865_CR26","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/s0049-3848(14)50007-2","volume":"133","author":"O Konigsbrugge","year":"2014","unstructured":"Konigsbrugge O, Pabinger I, Ay C (2014) Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS). Thromb Res 133(Suppl 2):S39-43. https:\/\/doi.org\/10.1016\/s0049-3848(14)50007-2","journal-title":"Thromb Res"},{"key":"3865_CR27","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1016\/s2352-3026(18)30063-2","volume":"5","author":"I Pabinger","year":"2018","unstructured":"Pabinger I, van Es N, Heinze G, Posch F, Riedl J, Reitter EM, Di Nisio M, Cesarman-Maus G, Kraaijpoel N, Zielinski CC, Buller HR, Ay C (2018) A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. Lancet Haematol 5:e289\u2013e298. https:\/\/doi.org\/10.1016\/s2352-3026(18)30063-2","journal-title":"Lancet Haematol"},{"key":"3865_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ajh.24700","volume":"92","author":"R Patell","year":"2017","unstructured":"Patell R, Rybicki L, McCrae KR, Khorana AA (2017) Predicting risk of venous thromboembolism in hospitalized cancer patients: Utility of a risk assessment tool. Am J Hematol 92:501\u2013507. https:\/\/doi.org\/10.1002\/ajh.24700","journal-title":"Am J Hematol"},{"key":"3865_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.thromres.2020.09.005","volume":"196","author":"S Shi","year":"2020","unstructured":"Shi S, Cheng J, Chen H, Zhang Y, Zhao Y, Wang B (2020) Preoperative and intraoperative predictors of deep venous thrombosis in adult patients undergoing craniotomy for brain tumors: a Chinese single-center, retrospective study. Thromb Res 196:245\u2013250. https:\/\/doi.org\/10.1016\/j.thromres.2020.09.005","journal-title":"Thromb Res"},{"key":"3865_CR30","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1200\/jco.2010.32.8294","volume":"29","author":"C Ay","year":"2011","unstructured":"Ay C, Dunkler D, Simanek R, Thaler J, Koder S, Marosi C, Zielinski C, Pabinger I (2011) Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol 29:2099\u20132103. https:\/\/doi.org\/10.1200\/jco.2010.32.8294","journal-title":"J Clin Oncol"},{"key":"3865_CR31","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/neuonc\/nou106","volume":"16","author":"J Thaler","year":"2014","unstructured":"Thaler J, Ay C, Kaider A, Reitter EM, Haselbock J, Mannhalter C, Zielinski C, Marosi C, Pabinger I (2014) Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas. Neuro Oncol 16:1645\u20131651. https:\/\/doi.org\/10.1093\/neuonc\/nou106","journal-title":"Neuro Oncol"},{"key":"3865_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11060-010-0290-x","volume":"102","author":"G Reynes","year":"2011","unstructured":"Reynes G, Vila V, Martin M, Parada A, Fleitas T, Reganon E, Martinez-Sales V (2011) Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma. J Neurooncol 102:35\u201341. https:\/\/doi.org\/10.1007\/s11060-010-0290-x","journal-title":"J Neurooncol"},{"key":"3865_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069034","volume":"8","author":"G Reynes","year":"2013","unstructured":"Reynes G, Vila V, Fleitas T, Reganon E, Font de Mora J, Jorda M, Martinez-Sales V (2013) Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma: prognostic value. PLoS ONE 8:e69034. https:\/\/doi.org\/10.1371\/journal.pone.0069034","journal-title":"PLoS ONE"},{"key":"3865_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/cyto.b.20551","volume":"80","author":"MG Macey","year":"2011","unstructured":"Macey MG, Enniks N, Bevan S (2011) Flow cytometric analysis of microparticle phenotype and their role in thrombin generation. Cytometry B 80:57\u201363. https:\/\/doi.org\/10.1002\/cyto.b.20551","journal-title":"Cytometry B"},{"key":"3865_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-021-02441-3","author":"SM Passamonti","year":"2021","unstructured":"Passamonti SM, Artoni A, Carrabba G, Merati G, Abbattista M, Capecchi M, Castellani M, Marenghi C, Trombetta E, Giammattei L, Caroli M, Bucciarelli P, Scalambrino E, Peyvandi F, Martinelli I (2021) Plasma levels of extracellular vesicles and the risk of post-operative pulmonary embolism in patients with primary brain tumors: a prospective study. J Thromb Thrombolys. https:\/\/doi.org\/10.1007\/s11239-021-02441-3","journal-title":"J Thromb Thrombolys"},{"issue":"Suppl 1","key":"3865_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1055\/s-2006-939555","volume":"32","author":"W Ruf","year":"2006","unstructured":"Ruf W, Mueller BM (2006) Thrombin generation and the pathogenesis of cancer. Semin Thromb Hemost 32(Suppl 1):61\u201368. https:\/\/doi.org\/10.1055\/s-2006-939555","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl 2","key":"3865_CR37","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/s0049-3848(10)70005-0","volume":"125","author":"C Ay","year":"2010","unstructured":"Ay C, Pabinger I (2010) Tests predictive of thrombosis in cancer. Thromb Res 125(Suppl 2):S12-15. https:\/\/doi.org\/10.1016\/s0049-3848(10)70005-0","journal-title":"Thromb Res"},{"key":"3865_CR38","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.thromres.2010.09.002","volume":"126","author":"F Debaugnies","year":"2010","unstructured":"Debaugnies F, Azerad MA, Noubouossie D, Rozen L, Hemker HC, Corazza F, Efira A, Demulder A (2010) Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay. Thromb Res 126:531\u2013535. https:\/\/doi.org\/10.1016\/j.thromres.2010.09.002","journal-title":"Thromb Res"},{"key":"3865_CR39","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1055\/s-0037-1613868","volume":"83","author":"HC Hemker","year":"2000","unstructured":"Hemker HC, Giesen PL, Ramjee M, Wagenvoord R, Beguin S (2000) The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 83:589\u2013591","journal-title":"Thromb Haemost"},{"key":"3865_CR40","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1111\/j.1538-7836.2005.01511.x","volume":"3","author":"CE Fadul","year":"2005","unstructured":"Fadul CE, Zacharski LR (2005) Coagulation biology in glioma pathogenesis: a missing link? J Thromb Haemost 3:1915\u20131916. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01511.x","journal-title":"J Thromb Haemost"},{"key":"3865_CR41","doi-asserted-by":"publisher","DOI":"10.5137\/1019-5149.Jtn.22739-18.3","author":"E Haciyakupo\u011flu","year":"2018","unstructured":"Haciyakupo\u011flu E, Yilmaz DM, Walter J, Erdo\u011fan \u015e, Haciyakupo\u011flu S, Kuhn SA (2018) Immunohistochemical evaluation of hemostatic changes in glioblastoma multiforme and low-grade astrocytoma. Turk Neurosurg. https:\/\/doi.org\/10.5137\/1019-5149.Jtn.22739-18.3","journal-title":"Turk Neurosurg"},{"key":"3865_CR42","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1055\/s-0033-1357483","volume":"39","author":"N Magnus","year":"2013","unstructured":"Magnus N, D\u2019Asti E, Garnier D, Meehan B, Rak J (2013) Brain neoplasms and coagulation. Semin Thromb Hemost 39:881\u2013895. https:\/\/doi.org\/10.1055\/s-0033-1357483","journal-title":"Semin Thromb Hemost"},{"key":"3865_CR43","doi-asserted-by":"publisher","first-page":"e621","DOI":"10.1016\/j.wneu.2018.09.177","volume":"121","author":"SE Navone","year":"2019","unstructured":"Navone SE, Guarnaccia L, Locatelli M, Rampini P, Caroli M, La Verde N, Gaudino C, Bettinardi N, Riboni L, Marfia G, Campanella R (2019) Significance and prognostic value of the coagulation profile in patients with glioblastoma: implications for personalized therapy. World Neurosurg 121:e621\u2013e629. https:\/\/doi.org\/10.1016\/j.wneu.2018.09.177","journal-title":"World Neurosurg"},{"key":"3865_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1055\/s-2002-20561","volume":"28","author":"DL Ornstein","year":"2002","unstructured":"Ornstein DL, Meehan KR, Zacharski LR (2002) The coagulation system as a target for the treatment of human gliomas. Semin Thromb Hemost 28:19\u201328. https:\/\/doi.org\/10.1055\/s-2002-20561","journal-title":"Semin Thromb Hemost"},{"key":"3865_CR45","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1160\/th12-12-0957","volume":"110","author":"MT Sartori","year":"2013","unstructured":"Sartori MT, Della Puppa A, Ballin A, Campello E, Radu CM, Saggiorato G, d\u2019Avella D, Scienza R, Cella G, Simioni P (2013) Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role. Thromb Haemost 110:378\u2013385. https:\/\/doi.org\/10.1160\/th12-12-0957","journal-title":"Thromb Haemost"},{"key":"3865_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/biom11050663","author":"MZ Wojtukiewicz","year":"2021","unstructured":"Wojtukiewicz MZ, Mysliwiec M, Matuszewska E, Sulkowski S, Zimnoch L, Politynska B, Wojtukiewicz AM, Tucker SC, Honn KV (2021) Imbalance in coagulation\/fibrinolysis inhibitors resulting in extravascular thrombin generation in gliomas of varying levels of malignancy. Biomolecules. https:\/\/doi.org\/10.3390\/biom11050663","journal-title":"Biomolecules"},{"issue":"Suppl 1","key":"3865_CR47","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/s0049-3848(20)30405-9","volume":"191","author":"N Tawil","year":"2020","unstructured":"Tawil N, Spinelli C, Bassawon R, Rak J (2020) Genetic and epigenetic regulation of cancer coagulome: lessons from heterogeneity of cancer cell populations. Thromb Res 191(Suppl 1):S99-s105. https:\/\/doi.org\/10.1016\/s0049-3848(20)30405-9","journal-title":"Thromb Res"},{"key":"3865_CR48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11060-010-0462-8","volume":"104","author":"MT Sartori","year":"2011","unstructured":"Sartori MT, Della Puppa A, Ballin A, Saggiorato G, Bernardi D, Padoan A, Scienza R, d\u2019Avella D, Cella G (2011) Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles. Journal Neurooncol 104:225\u2013231. https:\/\/doi.org\/10.1007\/s11060-010-0462-8","journal-title":"Journal Neurooncol"},{"key":"3865_CR49","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.thromres.2012.09.020","volume":"131","author":"J Thaler","year":"2013","unstructured":"Thaler J, Preusser M, Ay C, Kaider A, Marosi C, Zielinski C, Pabinger I, Hainfellner JA (2013) Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients. Thromb Res 131:162\u2013165. https:\/\/doi.org\/10.1016\/j.thromres.2012.09.020","journal-title":"Thromb Res"},{"key":"3865_CR50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.critrevonc.2017.08.003","volume":"118","author":"A Falanga","year":"2017","unstructured":"Falanga A, Russo L, Milesi V, Vignoli A (2017) Mechanisms and risk factors of thrombosis in cancer. Crit Rev Oncol Hematol 118:79\u201383. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.08.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"3865_CR51","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/neuonc\/now187","volume":"19","author":"BM Ellingson","year":"2017","unstructured":"Ellingson BM, Harris RJ, Woodworth DC, Leu K, Zaw O, Mason WP, Sahebjam S, Abrey LE, Aftab DT, Schwab GM, Hessel C, Lai A, Nghiemphu PL, Pope WB, Wen PY, Cloughesy TF (2017) Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials. Neuro Oncol 19:89\u201398. https:\/\/doi.org\/10.1093\/neuonc\/now187","journal-title":"Neuro Oncol"},{"key":"3865_CR52","doi-asserted-by":"publisher","first-page":"350","DOI":"10.7326\/0003-4819-149-5-200809020-00010","volume":"149","author":"DL Ornstein","year":"2008","unstructured":"Ornstein DL (2008) A nickel\u2019s worth of cancer. Ann Intern Med 149:350\u2013352. https:\/\/doi.org\/10.7326\/0003-4819-149-5-200809020-00010","journal-title":"Ann Intern Med"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03865-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-021-03865-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03865-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T08:08:04Z","timestamp":1636618084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-021-03865-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["3865"],"URL":"https:\/\/doi.org\/10.1007\/s11060-021-03865-w","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"23 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Camilo E. Fadul MD is a member of the Editorial Board of the Journal of Neuro-Oncology. Otherwise, the authors declare they have no relevant conflicts of interest or competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the Committee for the Protection of Human Subjects (CPHS) of Dartmouth College (study #D12096).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All study subjects provided written informed consent for participation in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}